MYCN and neuroblastoma: Furthermore, our studies do not suggest that reduced MYCN levels are the predominant effect of BMP4 treatment, Ferlemann et al. having suggested this based on MYCN reduction in the non-MNA neuroblastoma line SH-SY5Y [24].